| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on remeasurement of acquisition contingencies | - | - | 717,067 | - |
| Total other income (expense), net | -39,568 | 339,974 | 1,030,689 | 560,671 |
| Loss before income taxes | -7,053,416 | -7,717,790 | -7,521,267 | -9,674,266 |
| Income tax provision (benefit) | -1,166,593 | 12,327 | 12,004 | 22,189 |
| Net loss | -5,886,823 | -7,730,117 | -7,533,271 | -9,696,455 |
| Change in net unrealized gains (losses) on marketable securities, net of tax | -39,180 | -196,585 | -87,790 | 37,158 |
| Total other comprehensive income (loss) | -39,180 | -196,585 | -87,790 | 37,158 |
| Comprehensive loss | -5,926,003 | -7,926,702 | -7,621,061 | -9,659,297 |
| Basic | -0.16 | -0.23 | -0.24 | -0.32 |
| Basic | 37,890,923 | 33,108,399 | 32,048,953 | 30,494,206 |
| Diluted | -0.16 | -0.23 | -0.24 | -0.32 |
| Diluted | 37,890,923 | 33,108,399 | 32,048,953 | 30,494,206 |
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)